The Hymed Group Corporation
|
The Hymed Group Corporation
|
|
|
Company Profile The Hymed Group is a privately held company that manufactures human and veterinary products with applications in wound care and tissue protection. Since founded in 1995, The Hymed Group has formed strategic alliances with the following companies: PBI/Gordon Corporation, PRN Pharmacal, Neogen Corporation, and Wound Care Innovations, LLC. Hymed has been committed to providing healthcare professionals with the highest quality products and services and is dedicated to researching and developing new products that will enhance the health of the global community. Manufacturing facilities are located in Philadelphia, PA, Baltimore, MD and Hampstead, MD. The corporate philosophy is one that is embedded in the supposition, "that which is indigenous to the body, has benefit in its ability to heal itself." Using this philosophy as a foundation, The Hymed Group produces wound care products, chondroprotective agents and topicals that stimulate the body’s own natural healing abilities. Hymed’s products are based on collagen and glycosaminoglycan (sodium hyaluronate, chondroitin sulfate, glucosamine hydrochloride and others) chemistry. Unique to the marketplace, The Hymed Group’s products are patented. The medical industry has marveled at the products’ innovation and healing capabilities. Hymed is actively marketing its products through a global network of healthcare and veterinary distributors. Through these business ventures, exceptional growth of the company has been achieved. For more information concerning products, distribution opportunities, in-services and samples, please contact Anita M. Petito, Vice President by sending e-mail to: hymed@hymed.com or calling 610-865-9876. |
|
Send mail to Anita Petito with questions or
comments about this web site.
|